Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels ...

Novo Nordisk continues to deliver strong revenue, profit growth, and high economic profitability. Read why I rate NVO stock a ...

We recently published a list of Jim Cramer Had These 21 Stocks on His Radar. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that Jim ...

As the U.S. stock market navigates through a period of slight declines ahead of Nvidia's earnings report, investors are closely watching major indices like the Dow Jones and S&P 500, which have shown ...

A doctor has issued a stark 15-year warning to Ozempic users after the weight loss drug's brutal aftermath was revealed in a simulation ...

Veru reports strong safety and efficacy for enobosarm added to semaglutide, showing reduced functional decline and muscle ...

The CDC stopped recommending Covid shots for healthy children and pregnant women, while Hinge Health makes its debut on the ...

The company is preparing a Phase 3 trial of enobosarm with a novel formulation that could extend its patent life.